[Lambert-Eaton myasthenic syndrome].
Sahashi
K
K
Fourth Department of Medicine, Aichi Medical University.
D015761:4-Aminopyridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000077770:Amifampridine; D000974:Antibodies, Antinuclear / Q000032:analysis; D002648:Child; D004576:Electromyography; D005260:Female; D005861:Germine Acetates / Q000627:therapeutic use; D019791:Guanidine; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009469:Neuromuscular Junction / Q000473:pathology
D000974:Antibodies, Antinuclear; D005861:Germine Acetates; D006146:Guanidines; D015761:4-Aminopyridine; D019791:Guanidine; D000077770:Amifampridine